Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer

(2019) Peder Rustøen Braadland et al.   ENDOCRINE-RELATED CANCER

JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor Cells

(2018) Sihui Li et al.   Cell Reports

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

(2018) Qing-Jun Zhang et al.   Nature Communications

KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL

(2017) Ibrahim Cagri Kurt et al.   Cell Death & Disease

Assessing histone demethylase inhibitors in cells: lessons learned

(2017) Stephanie B. Hatch et al.   Epigenetics & Chromatin

KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling

(2017) Jiong Li et al.   Nature Communications

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

(2017) Alfonso Urbanucci et al.   Cell Reports

Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway

(2016) Jianwei Zhang et al.   EXPERIMENTAL CELL RESEARCH

Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1

(2016) Tae-Dong Kim et al.   JOURNAL OF CLINICAL INVESTIGATION

Recent Progress in Histone Demethylase Inhibitors

(2016) Tom E. McAllister et al.   JOURNAL OF MEDICINAL CHEMISTRY

c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer

(2016) Peterson Kariuki Maina et al.   Oncotarget

The HIF/PHF8/AR axis promotes prostate cancer progression

(2016) D Tong et al.   Oncogenesis

Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis

(2016) Lizhi Wu et al.   PLoS One

Transcriptional repression of ANGPT1 by histone H3K9 demethylase KDM3B

(2015) Arim Han et al.   BMB Reports

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia

(2015) Guro F Giskeødegård et al.   BRITISH JOURNAL OF CANCER

Integrative Clinical Genomics of Advanced Prostate Cancer

(2015) Dan Robinson et al.   CELL

KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes

(2015) Lingling Duan et al.   CHEMISTRY & BIOLOGY

Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells

(2015) Tanawan Kummalue et al.   EXPERIMENTAL HEMATOLOGY

Knockout of the Histone Demethylase Kdm3b Decreases Spermatogenesis and Impairs Male Sexual Behaviors

(2015) Zhaoliang Liu et al.   International Journal of Biological Sciences

Arginase: an old enzyme with new tricks

(2015) Ruth B. Caldwell et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Androgen receptor antagonists for prostate cancer therapy

(2014) Christine Helsen et al.   ENDOCRINE-RELATED CANCER

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing

(2014) Dirk Heckl et al.   NATURE BIOTECHNOLOGY

Epigenetics of Reprogramming to Induced Pluripotency

(2013) Bernadett Papp et al.   CELL

Control of Histone H3 Lysine 9 (H3K9) Methylation State via Cooperative Two-step Demethylation by Jumonji Domain Containing 1A (JMJD1A) Homodimer

(2013) Satoshi Goda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities

(2013) Dante Rotili et al.   JOURNAL OF MEDICINAL CHEMISTRY

Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics

(2013) Linn Fagerberg et al.   MOLECULAR & CELLULAR PROTEOMICS

Loss of Tumor Suppressor RPL5/RPL11 Does Not Induce Cell Cycle Arrest but Impedes Proliferation Due to Reduced Ribosome Content and Translation Capacity

(2013) T. Teng et al.   MOLECULAR AND CELLULAR BIOLOGY

The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover

(2013) Kelly Coffey et al.   NUCLEIC ACIDS RESEARCH

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

(2013) T Karantanos et al.   ONCOGENE

Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 Methylation

(2013) Michael Brauchle et al.   PLoS One

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation

(2013) Richard J. Hopkinson et al.   Chemical Science

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

(2013) Lei Wang et al.   Nature Communications

Histone lysine demethylases in breast cancer

(2012) Elisa Paolicchi et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer

(2012) Yongxia Liu et al.   GUT

KDM3B Is the H3K9 Demethylase Involved in Transcriptional Activation of lmo2 in Leukemia

(2012) J.-Y. Kim et al.   MOLECULAR AND CELLULAR BIOLOGY

The emerging role of histone lysine demethylases in prostate cancer

(2012) Francesco Crea et al.   Molecular Cancer

Chromatin-modifying enzymes as modulators of reprogramming

(2012) Tamer T. Onder et al.   NATURE

Adaptation or selection—mechanisms of castration-resistant prostate cancer

(2012) Yang Zong et al.   Nature Reviews Urology

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells

(2012) GIOVANNI LUCA GRAVINA et al.   ONCOLOGY REPORTS

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

(2012) K. Xu et al.   SCIENCE

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

The Epigenotype

(2011) C. H. Waddington   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

PC3 is a cell line characteristic of prostatic small cell carcinoma

(2011) Sheng Tai et al.   PROSTATE

A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes

(2011) Ruth N. MacKinnon et al.   Cancer Genetics

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

(2010) Shihua Sun et al.   JOURNAL OF CLINICAL INVESTIGATION

Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer

(2010) Philippe O. Gannon et al.   PLoS One

Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors

(2010) Oliver N. F. King et al.   PLoS One

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

(2008) R. B. Montgomery et al.   CANCER RESEARCH

Targeting the androgen receptor pathway in prostate cancer

(2008) Yu Chen et al.   CURRENT OPINION IN PHARMACOLOGY

H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome

(2008) F. M. Pauler et al.   GENOME RESEARCH